Data: 08/08/2026
Total encontrado: 9
1/9US=80 / Tese/FAP
Wainstein AJA. Imunogenicidade do vírus vacina recombinante modificado com o gene do antígeno carcino-embrionário (CEA) humano em modelo experimental de adenocarcinoma de cólon. [Immunogenicity of recombinant vaccinia virus modified with human carcinoembryonic antigen gene in an experimental model of colon adenocarcinoma]. São Paulo, 2003. 206 p. Tese(Doutorado)-Fundação Antonio Prudente.

Disponível em: http://accamargo.phlnet.com.br/Doutorado/2003/us80.pdf

Curriculum Lattes

IMUNOTERAPIA. USO TERAPEUTICO; RESPOSTA IMUNO MUCOSA. IMUNOLOGIA; CANCER DE COLON. GENETICA; CANCER DE COLON. IMUNOLOGIA; CANCER DE COLON. FISIOPATOLOGIA; CANCER DE COLON. TERAPIA; ONCOLOGIA; ANIMAIS TRANSGENICOS; VIRUS RECOMBINANTE; ANTIGENO CARCINO-EMBRIONARIO. IMUNOLOGIA; ANTIGENO CARCINO-EMBRIONARIO. USO TERAPEUTICO; POLIPOSE ADENOMATOSE DO COLON

2/9US=89 / Biol/Mol
Kim-Schulze S, Kaufman HL. Gene therapy for antitumor vaccination. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 515-27. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9.

TERAPIA GENETICA; VACINACAO ANTITUMORAL; IMUNOTERAPIA; MELANOMA; ANTIGENO TUMORAL; VIRUS VACCINIA

3/9US=89 / Biol/Mol
Thorne SH. Design and testing of novel oncolytic vaccinia strains. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 635-47. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9.

CANCER; VIRUS ONCOLITICO; REPLICACAO SELETIVA; VACCINIA; VIROTHERAPY

4/9US=105 / Câncer
Wansley EK. Poxviral vectors for cancer vaccines: state of the art. In: Orentas R, Hodge JW, Johnson BD. Cancer vaccines and tumor immunity. New Jersey: Wiley-Interscience, 2008. p. 95-111. ISBN 978-0-470-07474-9.

CANCER; VACINA; VETORES POXVIRAIS; VETORES VIRAIS; ANTIGENO ASSOCIADO AO TUMOR; VETORES TRICOM; CITOCINAS; VACCINIA ANKARA MODIFICADA (MVA)

5/9US=108 / Câncer
Harrigton KJ, Pandha HS, Vile RG. Poxviruses as immunomodulatory cancer therapeutics. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 95-114. ISBN 978-0-470-01922-1.

CANCER. TRATAMENTO; POXVIRUS; ESTRUTURA DO POXVIRUS; VIRUS VACCINIA; VACCINIA ANKARA MODIFICADA; AVIPOXVIRUS; YATAPOXVIRUS; VETORES

6/9US=108 / Câncer
Ziauddin MF, Bartlett DL. Oncolytic vaccinia. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 151-69. ISBN 978-0-470-01922-1.

VIRUS VACCINIA; RESPOSTA IMUNE; IMAGEM

7/9US=108 / Câncer
Schepelmann S, Hedley D, Ogilvie LM, Springer CJ. Gene-directed enzyme prodrug therapy. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 255-76. ISBN 978-0-470-01922-1.

TERAPIA GENICA; PRO-DROGA; PRO-FARMACO ATIVADO POR ENZIMA; GANCICLOVIR; TIMIDINA QUINASE; 5-FLUOROCITOSINA; CITOSINA DEAMINASE; CB1954; NITRORREDUTASE; CARBOXIPEPTIDASE G2; OXAZAPHOSPHORINES; CITOCROMO P450; FLUDARABINA; PURINA NUCLEOSIDEO FOSFORILASE; SELENOMETIONINA; METIONINASE; CPT-11; CARBOXILESTERASE; RETROVIRUS; ADENOVIRUS; VACCINIA; VIRUS HERPES SIMPLEX; VIRUS SINDBIS

8/9US=108 / Câncer
Boulanger D, Bateman A. Immunomodulatory gene therapy. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 277-94. ISBN 978-0-470-01922-1.

TERAPIA GENICA; IMUNOMODULADORES; IMUNOTERAPIA; VETORES VIRAIS; TERAPIA DO GENE SUICIDA; VIROTERAPIA; POXVIRUS; VIRUS VACCINIA; AVIPOXVIRUS; ADENOVIRUS; ALPHAVIRUS; VIRUS SEMLIKI FOREST; VIRUS SINDBIS; VIRUS HERPES; ANTIGENO CARCINOEMBRIONARIO; MELANOMA; TIROSINASE; GP100; CANCER COLORRETAL; CANCER DE PROSTATA; PAPILOMAVIRUS HUMANO; HPV

9/9US=95 / Biol/Mol
Chalikonda S, Barlett DL. Vectors: vaccinia and pox-virus. In: Hunt KK, Vorburger AS, Swisher SG. Gene therapy for cancer. New Jersey: Humana Press, 2007. p. 73-85. (Cancer Drug Discovery and Development) ISBN 978-0-470-19756-1.

CANCER; TERAPIA GENETICA; VETORES; VACCINIA; POX-VIRUS; VIRUS ONCOLITICOS; VIRUS ENVELOPADO EXTRACELULAR; VIRUS MADURO INTRACELULAR